J Am Soc Nephrol 13: 2534–2539, 2002
Cortisol Inhibits Acid-Induced Bone Resorption In Vitro NANCY S. KRIEGER, KEVIN K. FRICK, and DAVID A. BUSHINSKY Department of Medicine, Nephrology Unit, University of Rochester School of Medicine, Rochester, New York.
Abstract. Metabolic acidosis increases urine calcium excretion without an increase in intestinal calcium absorption, resulting in a net loss of bone mineral. In vitro, metabolic acidosis has been shown to initially induce physicochemical mineral dissolution and then enhance cell-mediated bone resorption. Acidic medium stimulates osteoblastic prostaglandin E2 production, which mediates the subsequent stimulation of osteoclastic bone resorption. Glucocorticoids are also known to decrease bone mineral density, and metabolic acidosis has been shown to increase glucocorticoid production. This study tested the hypothesis that glucocorticoids would exacerbate acid-induced net calcium efflux from bone. Neonatal mouse calvariae were cultured in acid (Acid; pH ⫽ 7.06 ⫾ 0.01; [HCO3⫺] ⫽ 10.6 ⫾ 0.3 mM) or neutral (Ntl; pH ⫽ 7.43 ⫾ 0.01; [HCO3⫺] ⫽ 26.2 ⫾ 0.5 mM) medium, with or without 1 M cortisol (Cort), and net calcium efflux and medium prostaglandin E2 (PGE2) levels
and osteoclastic -glucuronidase activity were determined. Compared with Ntl, Cort alone decreased calcium efflux, medium PGE2, and osteoclast activity; Acid led to an increase in all three parameters. The addition of Cort to Acid led to a reduction of calcium efflux, medium PGE2 levels and -glucuronidase activity compared with Acid alone. There was a significant direct correlation between medium PGE2 concentration and net calcium efflux (r ⫽ 0.944; n ⫽ 23; P ⬍ 0.0001), between osteoclastic -glucuronidase activity and net calcium efflux (r ⫽ 0.663; n ⫽ 40; P ⬍ 0.001), and between medium PGE2 concentration and ⫺glucuronidase activity (r ⫽ 0.976; n ⫽ 4; P ⬍ 0.01). Thus, in vitro cortisol inhibits acid-induced, cell-mediated osteoclastic bone resorption through a decrease in osteoblastic PGE2 production. These results suggest that the osteopenia observed in response to metabolic acidosis in vivo is not due to an increase in endogenous cortisol production.
Metabolic acidosis, which is observed during renal insufficiency or failure or with defects in renal tubular acid excretion, increases renal calcium excretion without altering intestinal calcium absorption (1–3). As bone is the largest repository of calcium in the body, bone is thought to be the source of this additional urine calcium (4). Indeed metabolic acidosis is associated with a decrease in bone mineral content (5,6). In vitro studies have described the direct response of bone to an acid challenge. A physiologic reduction in medium pH has been shown to initially induce physicochemical mineral dissolution (7,8) over the first 3 h of culture. With prolonged incubation in acidic medium, there is decreased osteoblastic bone formation and increased osteoclastic resorption (9,10), all of which contribute to a net efflux of calcium from bone (6,11). This cell-mediated resorption appears due to increased osteoblastic prostaglandin E2 (PGE2) synthesis, leading to a suppression of osteoblastic bone formation and subsequent stimulation of osteoclastic bone resorption (12–14). Glucocorticoids lead to a dramatic decrease in bone mineral density, either when endogenously in excess or when administered exogenously (15). The mechanism by which glucocorticoids
decrease bone density is multifactorial. The osteopenia appears due to a complex combination of direct effects on bone formation (16 –19) and resorption (16,17,20) and indirect effects on calcium homeostasis, including decreased intestinal calcium absorption (20). There is evidence from both animal and human studies to suggest that metabolic acidosis stimulates an increase in cortisol production (21–23). The mechanism by which acidosis stimulates cortisol is not clear; in acute studies, infusion of acid into isolated canine adrenal glands did not stimulate cortisol secretion (24), suggesting there is not direct regulation of glucocorticoid synthesis in the adrenal gland. Chronic metabolic acidosis can increase cortisol production, and both acidosis and cortisol induce osteopenia; it is therefore important to determine whether glucocorticoids directly exacerbate acidinduced net calcium efflux from bone. That glucocorticoids could enhance acid-induced bone resorption has precedent in the study of muscle proteolysis (21,25,26). In muscle, acidosis is known to stimulate protein and essential amino acid breakdown through the ubiquitin-proteasome proteolytic pathway, a mechanism that requires glucocorticoids (21,27). This permissive effect of glucocorticoids appears to be due to regulation of mRNA levels of key enzymes in the degradative pathway (28). In this study, however, we found that cortisol inhibited acid-induced net calcium efflux, bone cell PGE2 production, and osteoclastic activity. These results suggest that cortisol does not contribute to acid-induced bone resorption.
Received April 23, 2002. Accepted July 4, 2002. Correspondence to Dr. Nancy S. Krieger, Associate Research Professor of Medicine and of Pharmacology and Physiology, University of Rochester School of Medicine, Nephrology Unit, 601 Elmwood Avenue, Box 675, Rochester, NY 14642. Phone: 585-275-5123; Fax: 585-442-9201; E-mail:
[email protected] 1046-6673/1310-2534 Journal of the American Society of Nephrology Copyright © 2002 by the American Society of Nephrology DOI: 10.1097/01.ASN.0000031721.19801.7C
Materials and Methods Organ Culture of Bone Neonatal (4- to 6-d-old) CD-1 mice (Charles River, Wilmington, MA) were killed, and their calvariae were removed by dissection
J Am Soc Nephrol 13: 2534–2539, 2002
Cortisol Inhibits Acid-Induced Bone Resorption
(7,10,12,29). Exactly 2.8 ml of Dulbecco’s modified Eagle medium (DMEM) containing 15% heat-inactivated horse serum, heparin sodium (10 U/ml), and potassium penicillin (100 U/ml) were preincubated at a fixed partial pressure of carbon dioxide (Pco2, 40 mmHg) at 37°C for 3 h in 35-mm dishes. After preincubation, 1 ml of medium was removed to determine initial medium pH and Pco2 and total calcium concentration and two calvariae were placed in each dish on a stainless steel wire grid. Calvariae were incubated for an initial 24 h and then moved to fresh similar preincubated medium for an additional 24 h. At the beginning and end of each incubation period, medium was removed and analyzed for pH, Pco2, and calcium. After the 24 to 48 h incubation period, medium was also immediately analyzed for medium PGE2 or -glucuronidase concentrations.
Experimental Groups Calvariae were divided into four groups. Calvariae were incubated in medium either at neutral (Ntl) pH (approximately 7.4) or acidic (Acid) pH (approximately 7.1) produced by a primary decrease in the [HCO3⫺], to model metabolic acidosis (Met), with or without 1 m cortisol (Cort). To closely replicate physiologic conditions, only the HCO3⫺/CO2 buffer system was used (30). To reduce medium pH, 2.4 N HCl was added to the medium to obtain the desired reduction of [HCO3⫺] and thus pH.
Prostaglandin E2 Enzyme Immunoassay Culture medium was analyzed for PGE2 production by the calvariae immediately after the end of the second 24-h incubation, using an enzyme immunoassay kit obtained from Cayman Chemical (Ann Arbor, MI). Quantitation was done using a Dynatech MR700 microplate reader and Immunosoft computer program.
-Glucuronidase Activity
2535
Conventional Measurements Medium pH and Pco2 were determined with a blood-gas analyzer (Radiometer model ABL 5, Copenhagen, Denmark) and calcium by ion-selective electrode (Nova Biomedical, Waltham, MA). The concentration of bicarbonate ([HCO3⫺]) was calculated from pH and Pco2 as described previously (29). Net calcium (Ca) flux was calculated as Vm ⫻ ([Ca]f ⫺ [Ca]i), where Vm is the medium volume (1.8 ml) and [Ca]f and [Ca]i are the final and initial medium Ca concentrations, respectively. A positive flux value indicates movement of Ca from the bone into the medium, and a negative value indicates movement from the medium into the bone.
Statistical Analyses All tests of significance were calculated using ANOVA, with Bonferroni correction for multiple comparisons, and regression analysis using conventional computer programs (BMDP New System, Statistical Solutions, Cork, Ireland). Values are expressed as mean ⫾ SEM, and P ⱕ 0.05 was considered significant.
Results
Medium pH, Pco2, and [HCO3⫺] When compared with Ntl, there was no difference in the initial medium pH and [HCO3⫺] in the Cort group during either the 0 to 24 h time period or the 24 to 48 h time period (Table 1). When compared with Ntl and to Cort during each of the two time periods, there was a significant decrease in medium pH due to a decrease in medium [HCO3⫺] in both the Acid group and the Acid ⫹ Cort group. There was no difference in initial medium pH or [HCO3⫺] between the two groups incubated in Acid medium. There was no difference in the Pco2 in any group during either time period.
Net Calcium Flux
Culture medium was collected at the end of the second 24-h incubation. Medium -glucuronidase activity was determined colorimetrically using phenolphthalein glucuronidate (Sigma, St. Louis, MO) as a substrate (31).
During the first and the second 24-h period and over the cumulative 48-hr time period, there was significantly less calcium efflux from calvariae incubated with 1 M cortisol (Cort) when compared with Ntl (Figure 1). When compared
Table 1. Initial medium ion concentrationsa
n pH 0 to 24 h 24 to 48 h Pco2 (mm Hg) 0 to 24 h 24 to 48 h [HCO3] (meq/L) 0 to 24 h 24 to 48 h
Ntl
Cort
Acid
Acid ⫹ Cort
20
19
20
20
7.43 ⫾ 0.01 7.43 ⫾ 0.01
7.43 ⫾ 0.01 7.43 ⫾ 0.01
7.06 ⫾ 0.01bc 7.06 ⫾ 0.01bc
7.05 ⫾ 0.01bc 7.06 ⫾ 0.01bc
39.4 ⫾ 0.7 39.8 ⫾ 0.6
38.1 ⫾ 1.7 39.4 ⫾ 0.4
39.2 ⫾ 0.5 39.6 ⫾ 0.7
39.8 ⫾ 0.6 39.6 ⫾ 0.6
26.2 ⫾ 0.5 26.2 ⫾ 0.5
26.0 ⫾ 0.5 26.5 ⫾ 0.6
10.6 ⫾ 0.3bc 10.8 ⫾ 0.4bc
10.6 ⫾ 0.4bc 10.7 ⫾ 0.4bc
Data are the mean ⫾ SEM. Neonatal mouse calvariae were cultured in neutral (Ntl) or acid (Acid) medium in the absence or presence of 1 M cortisol (Cort) as indicated for 24 h (0 to 24 h) and reincubated in similar fresh medium for a second 24 h (24 to 48 h). Pco2, partial pressure of carbon dioxide; [HCO3], medium bicarbonate concentration. b P ⬍ 0.05 versus Ntl. c P ⬍ 0.05 versus Cort. a
2536
Journal of the American Society of Nephrology
J Am Soc Nephrol 13: 2534–2539, 2002
icant direct correlation between medium PGE2 concentration and net calcium flux (Figure 3).
Medium -Glucuronidase Activity
Figure 1. Effect of cortisol on acid-induced net calcium flux. Neonatal mouse calvariae were cultured in neutral (Ntl) or acid (Acid) medium in the absence or presence of 1 M cortisol (Cort) as indicated for 24 h (0 to 24 h) and reincubated in similar fresh medium for a second 24-h period (24 to 48 h). Data are the mean ⫾ SEM for 19 to 20 pairs of bones in each group; *P ⬍ 0.05 versus Ntl; ⫹P ⬍ 0.05 versus Cort; o P ⬍ 0.05 versus Acid alone.
with both Ntl and Cort, incubation in Acid medium with or without Cort led to a significant increase in net calcium efflux during each individual 24-h period and during the cumulative 48-hr period. However, when compared with Acid alone, incubation in Acid ⫹ Cort led to a significant decrease in net calcium efflux during each of the individual 24-h periods and during the cumulative 48-hr period.
Medium PGE2 Concentration When compared with Ntl, there was a decrease in medium PGE2 concentration from calvariae incubated with Cort (Figure 2). Compared with Ntl, incubation in Acid with or without Cort led to an increase in medium PGE2 concentration. However, incubation in Acid ⫹ Cort led to a fall in medium PGE2 concentration compared with Acid alone. There was a signif-
Figure 2. Effect of cortisol on acid-induced prostaglandin E2 (PGE2) concentration. Neonatal mouse calvariae were cultured in Ntl or Acid medium in the absence or presence of 1 M Cort as indicated for 24 h (0 to 24 h) and reincubated in similar fresh medium for a second 24-h period (24 to 48 h). Data shown are for the second incubation. Calcium fluxes are for the incubations subsequently used for PGE2 measurements. Data are the mean ⫾ SEM for 5 to 6 pairs of calvariae in each group; *P ⬍ 0.05 versus Ntl; ⫹P ⬍ 0.05 versus Cort; oP ⬍ 0.05 versus Acid alone.
When compared with Ntl, there was decrease in medium osteoclastic -glucuronidase activity from calvariae incubated with Cort (Figure 4). Compared with Ntl, incubation in Acid led to an increase in medium -glucuronidase activity. However, incubation in Acid ⫹ Cort led to a fall in medium -glucuronidase activity compared with Acid alone. There was a significant direct correlation between medium -glucuronidase activity and net calcium flux (Figure 5).
Correlation of Medium PGE2 Concentration and Medium -Glucuronidase Activity There was a significant direct correlation between the medium PGE2 concentration of each group and the medium -glucuronidase activity of each group (Figure 6). -glucuronidase activity is indicative of osteoclast activation; therefore, this suggests that the stimulation of osteoblastic PGE2 production by acidosis directly leads to increased osteoclast activation and subsequent bone resorption.
Discussion During renal insufficiency and renal failure and with specific abnormalities of renal tubular function, there is less hydrogen ion excretion than endogenous acid production, which results in a decrease in serum pH and bicarbonate, a disorder termed metabolic acidosis (30). Metabolic acidosis, both in vivo and in vitro, induces net calcium efflux from bone (6,11,32). Chronic metabolic acidosis, produced by feeding rats NH4Cl (21) or infusing dogs with NH4Cl (22), has also been shown to cause a significant increase in corticosteroid excretion. In a small human study, NH4Cl-induced acidosis was also associated with an increase in cortisol excretion (23); however, another similar study in humans did not show any increase in cortisol
Figure 3. Correlation between PGE2 concentration and net calcium flux. Neonatal mouse calvariae were cultured in neutral (squares) or acid (triangles) medium in the absence (open symbols) or presence (closed symbols) of 1 M cortisol for 24 h and reincubated in similar fresh medium for a second 24 h. Data shown are for the second incubation, and each symbol represents a pair of calvariae.
J Am Soc Nephrol 13: 2534–2539, 2002
Figure 4. Effect of cortisol on acid-induced -glucuronidase activity. Neonatal mouse calvariae were cultured in Ntl or Acid medium in the absence or presence of 1 M Cort as indicated for 24 h (0 to 24 h) and reincubated in similar fresh medium for a second 24-h period (24 to 48 h). Data shown are for the second incubation. Calcium fluxes are for the incubations subsequently used for the -glucuronidase activity measurements. Data are the mean ⫾ SEM for 10 pairs of calvariae in each group; *P ⬍ 0.05 versus Ntl; ⫹P ⬍ 0.05 versus Cort; oP ⬍ 0.05 versus Acid alone.
Figure 5. Correlation between -glucuronidase activity and net calcium flux. Neonatal mouse calvariae were cultured in neutral (squares) or acid (triangles) medium in the absence (open symbols) or presence (closed symbols) of 1 M cortisol for 24 h and reincubated in similar fresh medium for a second 24 h. Data shown are for the second incubation, and each symbol represents a pair of calvariae.
secretion, although plasma aldosterone levels significantly increased (33). Chronic metabolic acidosis could stimulate endogenous glucocorticoid production; we therefore tested the hypothesis that a glucocorticoid, cortisol, would directly exacerbate acid-induced net calcium efflux from bone. However, in contrast, we found that cortisol inhibited acid stimulation of net calcium efflux, bone cell PGE2 production, and osteoclastic activity. These results suggest that the osteopenia observed in vivo in response to acidosis is not augmented by an increase in cortisol production. When bone is cultured in acidic medium, there is an increase in net calcium efflux initially due to physicochemical dissolution (8,34) followed by a cell-mediated increase in bone resorption and decrease in bone formation (7,10). Acid medium stimulates osteoblastic PGE2 production, which mediates the
Cortisol Inhibits Acid-Induced Bone Resorption
2537
Figure 6. Correlation between PGE2 concentration and -glucuronidase activity. Neonatal mouse calvariae were cultured in neutral (square) or acid (triangle) medium in the absence (open symbol) or presence (closed symbol) of 1 M cortisol for 24 h and reincubated in similar fresh medium for a second 24 h. Data shown are for the second incubation, and each symbol represents the mean and SEM for each group. Absence of error bars indicates that the SE was less than the width of the symbol.
subsequent stimulation of osteoclastic bone resorption (12– 14,35). Cortisol has previously been shown to inhibit prostaglandin production (36) as well as hormonal stimulation of the rate-limiting enzyme that converts arachidonic acid to PGE2 (prostaglandin G/H synthase, PGHS-2) in neonatal mouse calvariae (37). Cortisol also inhibited serum stimulation of PGHS-2 mRNA levels in MC3T3-E1 mouse osteoblastic cells (38). In the results presented here, we demonstrate that cortisol inhibits acid-induced bone resorption, apparently through its ability to inhibit PGE2 production in the osteoblast. There is a direct correlation between net calcium efflux and PGE2 production both in the presence and absence of cortisol as well as a direct correlation between medium PGE2 concentration and -glucuronidase activity, a measure of osteoclastic activity. This supports the idea that PGE2 production stimulated by acidosis mediates the subsequent acid-induced osteoclastic bone resorption. Glucocorticoids stimulate net bone resorption in vivo; however, both inhibition (36,39,40) as well as stimulation (41,42) of bone resorption have been reported using bone organ culture systems. Glucocorticoids have been shown to inhibit bone cell proliferation (43) and have a biphasic effect on type I collagen synthesis, a principal function of the osteoblast (16,44 – 46). In addition to being dose- and treatment time-dependent, the effects of glucocorticoids also seem to depend on the stage of osteoblast differentiation. Glucocorticoids decrease bone formation via suppression of osteoblast maturation and promotion of apoptosis (19). Glucocorticoids also inhibit production of osteoprotegerin, a soluble neutralizing receptor produced by
2538
Journal of the American Society of Nephrology
osteoblasts, which limits osteoclastogenesis (47). Glucocorticoids stimulate the expression and action of bone morphogenic proteins, which could account for their ability to promote osteoblast differentiation in some model systems. However, they also suppress the effect of CBFA1, a nuclear transcription factor critical for bone formation (16,48). It is not certain how the net response to glucocorticoids in vivo manifests itself with respect to these opposing responses. Glucocorticoid-induced osteopenia in vivo has been well characterized (19,49), although the exact mechanism of induction of the resultant loss of bone mineral is not entirely understood. In general, there appears to be an uncoupling of bone remodeling to favor bone resorption over bone formation (20). Presumably this is due to an overall inhibition of osteoblastic proliferation and biosynthetic activity and stimulation of osteoclastic activity. In addition to direct effects on skeletal function, glucocorticoids also decrease intestinal calcium absorption and at higher doses increase urinary calcium excretion. Thus, the net osteopenia observed in vivo after glucocorticoid treatment is probably due to a complex combination of direct effects on bone formation and resorption as well as indirect effects to inhibit intestinal calcium absorption and increase renal calcium excretion (17,20,50,51). In this study, we examined a direct effect of cortisol on acid-induced bone mineral resorption. We did not study any potential interaction of glucocorticoids and acidosis on overall total body calcium homeostasis. Thus we cannot rule out that an acid-induced increase in cortisol in vivo could contribute to the net loss of bone mineral through more indirect mechanisms, such as alteration of intestinal calcium absorption or renal calcium excretion, that were not studied here. We have demonstrated that in vitro the addition of cortisol to acid medium does not increase, but rather inhibits, acid-induced calcium efflux from bone, suggesting that any acidosis-induced increase in cortisol will not directly increase acid-induced bone resorption. However, even though cultured neonatal mouse calvariae respond to protons and calcium-regulating hormones, synthesize DNA and protein, and have functioning osteoblasts and osteoclasts (52), as human bone does in vivo, it is not clear whether these results obtained in vitro are applicable to human bone perfused by blood. Without clinical studies confirming this in vitro work, it is premature to consider the use of cortisol, or any inhibitor of prostaglandin synthesis, to inhibit acidinduced bone resorption in humans.
Acknowledgment This work was supported in part by National Institutes of Health Grants AR 46289 and DK 56788 funds from the Renal Research Institute.
References 1. Lemann J Jr, Litzow JR, Lennon EJ: Studies of the mechanism by which chronic metabolic acidosis augments urinary calcium excretion in man. J Clin Invest 46: 1318 –1328, 1967 2. Lemann J Jr, Adams ND, Gray RW: Urinary calcium excretion in human beings. N Engl J Med 301: 535–541, 1979
J Am Soc Nephrol 13: 2534–2539, 2002
3. Lemann J Jr, Gray RW, Maierhofer WJ, Cheung HS: The importance of renal net acid excretion as a determinant of fasting urinary calcium excretion. Kidney Int 29: 743–746, 1986 4. Widdowson EM, Dickerson JWT: Chemical composition of the body. In: Mineral Metabolism, edited by Comar CL, Bronner F, New York, Academic Press, Inc., 1964, pp 1–247 5. Bushinsky DA: Hydrogen Ions. In: Renal Osteodystrophy, edited by Bushinsky DA, Philadelphia, Lippincott-Raven, 1998, pp 103–127 6. Bushinsky DA, Frick KK: The effects of acid on bone. Curr Opin Nephrol Hypertens 9: 369 –379, 2000 7. Bushinsky DA, Goldring JM, Coe FL: Cellular contribution to pH-mediated calcium flux in neonatal mouse calvariae. Am J Physiol Renal Fluid Electrolyte Physiol 17: 248: F785–F789, 1985 8. Bushinsky DA, Wolbach W, Sessler NE, Mogilevsky R, LeviSetti R: Physicochemical effects of acidosis on bone calcium flux and surface ion composition. J Bone Min Res 8: 93–102, 1993 9. Bushinsky DA: Stimulated osteoclastic and suppressed osteoblastic activity in metabolic but not respiratory acidosis. Am J Physiol 268: C80 –C88, 1995 10. Krieger NS, Sessler NE, Bushinsky DA: Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro. Am J Physiol Renal Fluid Electrolyte Physiol 31: F442-F448, 1992 11. Bushinsky DA: The contribution of acidosis to renal osteodystrophy. Kidney Int 47: 1816 –1832, 1995 12. Krieger NS, Parker WR, Alexander KM, Bushinsky DA: Prostaglandins regulate acid-induced cell-mediated bone resorption. Am J Physiol Renal Physiol 279: F1077–F1082, 2000 13. Rabadjija L, Brown EM, Swartz SL, Chen CJ, Goldhaber P: H⫹ -stimulated release of prostaglandin E2 and cyclic adenosine 3', 5'-monophosphoric acid and their relationship to bone resorption in neonatal mouse calvaria cultures. Bone Miner 11: 295–304, 1990 14. Bushinsky DA, Parker WR, Alexander KM, Krieger NS: Metabolic, but not respiratory, acidosis increases bone PGE2 levels and calcium release. Am J Physiol Renal Physiol 281: F1058 – F1066, 2001 15. Kumar R: Glucocorticoid-induced osteoporosis. Curr Opin Nephrol Hypertens 10: 589 –595, 2001 16. Delany AM, Dong Y, Canalis E: Mechanisms of glucocorticoid action in bone cells. J Cell Biochem 56: 295–302, 1994 17. Canalis E: Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81: 3441–3447, 1996 18. Cooper MS, Hewiston M, Stewart PM: Glucocorticoid activity, inactivity and the osteoblast. J Endocrinol 163: 159 –164, 1999 19. Manolagas SC, Weinstein RS: New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 14: 1061–1066, 1999 20. Lane NE: An update on glucocorticoid-induced osteoporosis. Rheum Dis Clin North Am 27: 235–253, 2001 21. May R, Kelly R, Mitch WE: Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. J Clin Invest 77: 614 – 621, 1986 22. Perez GO, Oster JR, Katz FH, Vaamonde CA: The effect of acute metabolic acidosis on plasma cortisol, renin activity and aldosterone. Horm Res 11: 12–21, 1979 23. Sicuro A, Mahlbacher K, Hulter HN, Krapf R: Effect of growth hormone on renal and systemic acid-base homeostasis in humans. Am J Physiol 274: F650 –F657, 1998
J Am Soc Nephrol 13: 2534–2539, 2002
24. Radke KJ, Schneider EG, Taylor Jr. RE, Kramer RE: Effect of hydrogen ion concentration on corticosteroid secretion. Am J Physiol 250: E259 –E264, 1986 25. Reaich D, Price SR, England BK, Mitch WE: Mechanisms causing muscle loss in chronic renal failure. Am J Kid Dis 26: 242–247, 1995 26. Mitch WE, Price SR: Mechanisms activated by kidney disease and the loss of muscle mass. Am J Kid Dis 38: 1337–1342, 2001 27. Mitch WE, Medina R, Grieber S, May R, England BK, Price SR, Bailey J, Goldberg A: Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphatedependent pathway involving ubiquitin and proteasomes. J Clin Invest 93: 2127–2133, 1994 28. Isozaki Y, Mitch WE, England BK, Price SR: Protein degradation and increased mRNAs encoding proteins of the ubiquitinproteasome proteolytic pathway in BC3H1 myocytes require an interaction between glucocorticoids and acidification. Proc Natl Acad Sci 93: 1967–1971, 1996 29. Bushinsky DA, Krieger NS, Geisser DI, Grossman EB, Coe FL: Effects of pH on bone calcium and proton fluxes in vitro. Am J Physiol Renal Fluid Electrolyte Physiol 14: 245: F204 –F209, 1983 30. Bushinsky DA: Metabolic acidosis. In: The Principles and Practice of Nephrology, edited by Jacobson HR, Striker GE, Klahr S, St. Louis, Mosby, 1995, pp 924 –932 31. Krieger NS, Stappenbeck TS, Stern PH: Cardiotonic agent milrinone stimulates resorption in rodent bone organ culture. J Clin Invest 79: 444 – 448, 1987 32. Bushinsky DA: Acid-base imbalance and the skeleton. In: Nutritional Aspects of Osteoporosis, edited by Burckhardt P, Dawson-Hughes B, Heaney RP, Norwell, MA, Serono Symposia USA, 1998, pp 208 –217 33. Schambelan M, Sebastian A, Katuna BA, Arteaga E: Adrenocortical hormone secretory response to chronic NH4CI-induced metabolic acidosis. Am J Physiol 252: E454 –E460, 1987 34. Bushinsky DA, Lechleider RJ: Mechanism of proton-induced bone calcium release: Calcium carbonate-dissolution. Am J Physiol Renal Fluid Electrolyte Physiol 22: 253: F998 –F1005, 1987 35. Goldhaber P, Rabadjija L: H⫹ stimulation of cell-mediated bone resorption in tissue culture. Am J Physiol Endocrinol Metab 16: 253: E90 –E98, 1987 36. Marusic A, Raisz LG: Cortisol modulates the actions of interleukin-1a on bone formation, resorption, and prostaglandin production in cultured mouse parietal bones. Endocrinology 129: 2699 –2706, 1991 37. Kawaguchi H, Raisz LG, Voznesensky OS, Alander CB, Hakeda Y, Pilbeam CC: Regulation of the two prostaglandin G/H synthases by parathyroid hormone, interleukin-1, cortisol and prostaglandin E2 in cultured neonatal mouse calvariae. Endocrinol 135: 1157–1164, 1994 38. Pilbeam CC, Kawaguchi H, Hakeda Y, Voznesensky O, Alander CB, Raisz LG: Differential regulation of the inducible and con-
Cortisol Inhibits Acid-Induced Bone Resorption
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
2539
stitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells. J Biol Chem 268: 25643–25649, 1993 Stern PH: Inhibition by steroids of parathyroid hormone-induced 45 Ca release from embryonic rat bone in vitro. J Pharm Exp Ther 168: 211–217, 1969 Raisz LG, Trummel CL, Wener JA, Simmons H: Effect of glucocorticoids on bone resorption in tissue culture. Endocrinology 90: 961–967, 1972 Reid IR, Katz J, Ibbertson H, Gray DH: The effects of hycrocortisone, parathyroid hormone and the bisphosphonate, APD, on bone resorption in neonatal mouse calvaria. Calc Tiss Int 38: 38 – 43, 1986 Gronowicz G, McCarthy MB, Raisz LG: Glucocorticoids stimulate resorption in fetal rat parietal bones in vitro. J Bone Min Res 5: 1223–1230, 1990 Chen TL, Aronow L, Feldman D: Glucocorticoid receptors and inhibition of bone cell growth in primary culture. Endocrinology 100: 619 – 628, 1977 Dietrich JW, Canalis EM, Maina DM, Raisz LG: Effects of glucocorticoids on fetal rat bone collagen synthesis in vitro. Endocrinology 104: 715–721, 1979 Canalis E: Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity and deoxyribonucleic acid content in cultured rat calvariae. Endocrinology 112: 931–939, 1983 Hahn TJ, Westbrook SL, Halstead LR: Cortisol modulation of osteoblast metabolic activity in cultured neonatal rat bone. Endocrinology 114: 1864 –1870, 1984 Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S: Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinol 140: 4382– 4389, 1999 Chang DJ, Ji C, Kim KK, Casingtino S, McCarthy TL, Centrella M: Reduction in transforming growth factor beta receptor I expression and transcription factor cbta1 on bone cells by glucocorticoid. J Biol Chem 273: 4792– 4856, 1998 Lukert BP, Raisz LG: Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 112: 352–364, 1990 Hahn TJ: Steroid hormones and the skeleton. In: Metabolic Bone Disease: Cellular and Tissue Mechanisms, edited by Tam CS, Heersche JNM, Murray TM, Boca Raton, FL, CRC Press, Inc., 1989, pp 223–237 Fucik RF, Kukreja SC, Hargis GK, Bowser EN, Henderson WJ, Williams GA: Effect of glucocorticoids on function of the parathyroid glands in man. J Clin Endo Metab 40: 152–155, 1975 Stern PH, Raisz LG: Organ culture of bone. In: Skeletal Research, edited by Simmons DJ, Kunin AS, New York, Academic Press, 1979, pp 21–59
